Clinical Trials Logo

Clinical Trial Summary

ASSISTENT is designed to collect comprehensive information on technical and clinical safety of the use of Credo® stent together with the NeuroSpeed® PTA balloon catheter in clinical practice in an open registry.


Clinical Trial Description

ASSISTENT is subdivided into two components. The first part only requires recording of data acquired in routine clinical practice during the treatment of patients with intracranial stenosis with the self-expandable Credo® stent until discharge. This comprises demographic data, data concerning the qualifying clinical event, limited data on medical history and medication, information about the intervention including technical success and periprocedural complications or events, and information about events and clinical status during the in-hospital treatment until hospital discharge. The second part of the registry consists of a follow-up visit 30 days after the interventional procedure which will be conducted outside of clinical practice. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03902444
Study type Observational
Source Acandis GmbH
Contact Acandis GmbH
Phone +49 723 1155 00
Email info@acandis.com
Status Recruiting
Phase
Start date May 2016
Completion date October 2025

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05583305 - Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome
Not yet recruiting NCT05270746 - The Predictive Value of Retinal Vascular Signs for Intracranial Artery Stenosis (RVS-ICAS)
Active, not recruiting NCT05403593 - Registry of Emergent Large veSsel oCclUsion duE to IntraCranial AtherosclerosiS
Terminated NCT03955835 - Acandis Credo Intracranial Stent for Unsuccessful Recanalization After Thrombectomy (ACUTE) N/A
Completed NCT02506907 - Characterizing Hemodynamic Compensation in Patients With Intracranial Stenosis N/A